PH

Piper Heartland Healthcare Capital

North America, Minnesota, United States, Minneapolis

Description

Piper Heartland Healthcare Capital is a buyout fund managed by Piper Sandler.

Investor Profile

Piper Heartland Healthcare Capital has backed more than 14 startups, with 4 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 6 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series B, Series A rounds (top funding stages).
  • Majority of deals are located in United States, Switzerland.
  • Strong thematic focus on Biotechnology, Therapeutics, Health Care.

Stage Focus

  • Series C (50%)
  • Series B (29%)
  • Series A (7%)
  • Series D (7%)
  • Series Unknown (7%)

Country Focus

  • United States (93%)
  • Switzerland (7%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Health Care
  • Medical
  • Life Science
  • Biopharma
  • Oncology
  • Pharmaceutical
  • Precision Medicine
  • Apps
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Piper Heartland Healthcare Capital frequently co-invest with?

Wellington Management
North America, Massachusetts, United States, Boston
Co-Investments: 4
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 4
Omega Funds
Europe, Geneve, Switzerland, Geneva
Co-Investments: 5
T. Rowe Price
North America, Maryland, United States, Baltimore
Co-Investments: 6
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 5
Ally Bridge Group
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 6
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 4
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 4
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 4
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 4

Which angels does Piper Heartland Healthcare Capital often collaborate with?

PT
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Piper Heartland Healthcare Capital?

Artios Pharma

Cambridge, Cambridgeshire, United Kingdom

Artios Pharma is a biopharmaceutical company that provides new solutions in the DNA damage response (DDR) field.

BiopharmaBiotechnologyMedical Device
Series DNov 17, 2025
Amount Raised: $115,000,000
Avalyn Pharma

Seattle, Washington, United States

Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.

BiopharmaBiotechnologyMedicalPharmaceutical
Series DJul 22, 2025
Amount Raised: $100,000,000
Kardium

Burnaby, British Columbia, Canada

Kardium is a medical solutions company that develops a globe pulsed field system for the diagnosis and treatment of atrial fibrillation.

HardwareHealth DiagnosticsManufacturingMedicalMedical Device
Private EquityJul 2, 2025
Amount Raised: $249,198,899
Arbor Biotechnologies

Cambridge, Massachusetts, United States

Arbor Biotechnologies is a biotechnology company specializing in next-generation gene editing therapeutics to treat genetic diseases.

BiopharmaBiotechnologyLife Science
Series CMar 18, 2025
Amount Raised: $73,900,000
Saluda Medical

Bloomington, Minnesota, United States

Saluda Medical is a commercial-stage medical device company that develops treatments for chronic neurological conditions.

Health CareMedicalMedical DeviceTherapeutics
Series UnknownJan 10, 2025
Amount Raised: $100,000,000
Alentis Therapeutics

Allschwil, Basel-Landschaft, Switzerland

ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.

BiotechnologyManufacturingPharmaceuticalTherapeutics
Series DNov 12, 2024
Amount Raised: $181,400,000
AvenCell

Watertown, Massachusetts, United States

Based on our deep science and focused on patients in need.

Health Care
Series BOct 22, 2024
Amount Raised: $112,000,000
Endeavor BioMedicines

Solana Beach, California, United States

Endeavor BioMedicines develops new treatments targeting the underlying causes of pulmonary fibrosis.

BiotechnologyHealth CareMedical
Series CApr 24, 2024
Amount Raised: $132,500,000
Alumis

San Francisco, California, United States

Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.

BiotechnologyHealth CareLife SciencePrecision Medicine
Series CMar 6, 2024
Amount Raised: $259,000,000
ProfoundBio

Seattle, Washington, United States

ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.

BiotechnologyOncologyTherapeutics
Series BFeb 13, 2024
Amount Raised: $112,000,000

Find More Investors Like Piper Heartland Healthcare Capital

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Piper Heartland Healthcare Capital | Pipeseed